- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02162290
Comparison Between Moderate-high Interval Exercise and Moderate Continuous Exercise in an Advanced Cardiac Rehabilitation Program
May 15, 2016 updated by: Assaf-Harofeh Medical Center
Comparison Between Moderate-high Interval Exercise and Moderate Continuous Exercise in an Advanced Cardiac Rehabilitation Program - Nine Months Follow up
The research will study the differences between interval training and continuous training among cardiac patients in a cardiac rehabilitation facility.
The main objectives are:
- Functional capacity measures (VO2 max).
- Cardiac risk factors
- Quality of life assessments.
Study hypothesis:
Interval training will be more effective in improving functional capacity, cardiac risk factors and quality of life, compared to continuous training.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
84
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Beer Yaacov, Israel
- Asaf Harofe Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
Patients undergone:
- Myocardial infarction
- Percutaneous transluminal coronary angioplasty
- Coronary artery bypass graft
Exclusion Criteria:
Patients with:
- Severe ischemia or angina
- Implantable cardioverter-defibrillator
- Pacemakers transplants
- Severe left ventricular dysfunctions
- Uncontrolled arrhythmias
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Interval exercise
Exercise bouts in low and high intensities
|
Exercise bouts in low and high intensities
|
|
Experimental: Continuous exercise
Exercise continuously with moderate intensity
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Maximal functional capacity
Time Frame: 9 months
|
Outcome is assessed at baseline, after 3 months and at nine months
|
9 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Yael Pernick, Asaf Harofe Medical Center
- Study Director: Zyssman, MD, Asaf Harofe Medical Center
- Study Director: Jonathan Moore, PhD, Bangor University
- Study Director: Zvi Vered, MD, Asaf Harofe Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2011
Primary Completion (Actual)
May 1, 2015
Study Completion (Actual)
May 1, 2015
Study Registration Dates
First Submitted
June 11, 2014
First Submitted That Met QC Criteria
June 11, 2014
First Posted (Estimate)
June 12, 2014
Study Record Updates
Last Update Posted (Estimate)
May 17, 2016
Last Update Submitted That Met QC Criteria
May 15, 2016
Last Verified
May 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2*175/10
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.